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Abstract
Aims and background
The aim of our research was to use lymphoscintigraphy as a main method to confirm and detect 
lymph nodes in the neck, in patients with squamos cell carcinoma of lower lip which were clinically
T1, T2 and N0, and to justify the use of selective neck dissection in those patients.
Methods
From April 2010  to January 2011, 31 patients with T1, T2 and N0 SCC of the lower lip were 
admitted to our center. To detect sentinel lymph nodes, we performed  lymphoscintigraphy (LSG). 
LSG was performed on the day of surgery after intradermal injection of 37 Mbq of 
Tc99m-Sn-colloid/ml at four peritumoral sites. The sentinel lymph nodes were then extirpated and 
sent for biopsy.Results
Among the 31 patients, three (9.7%) were female and 28 (90.3%) were male. LSG detected sentinel 
nodes in the neck in 21 (67.7%) of the patients. Of these, 10 (47.6%) had a positive sentinel node 
biopsy. Of all 31 patients enrolled in the study, occult metastases were found in 10 (32.3%). 
Conclusions
Our results indicate that, of the methods used to detect positive lymph nodes, the most accurate is 
LSG. The results also suggest that further study is needed to optimize the treatment protocol in 
patients with SCC of the lower lip, especially in those with T2 lesions.
Introduction
Squamous cell carcinoma (SCC) of the lower lip is one of the most frequently diagnosed malignant 
pathologies in the maxillofacial region. After skin cancer, lip cancer is the second most frequent 
cancer in the maxillofacial region[1,2]. Over 15 years in our department, we have treated 789 
patients with SCC of the lower lip, the majority of whom were male (89%). Those with T1 and T2 
lesions had a better prognosis [3]. Carcinoma of the lower lip is not an aggressive cancer. Because it
grows slowly, it can be diagnosed and treated easily and effectively; however, the early treatment of
carcinoma of the lower lip is important because the mortality is still 10–30%. The recommended 
protocol for the treatment of carcinoma of the lower lip in patients with clinically negative neck 
lymph nodes is to "wait and see"[4]. Precise diagnosis of malignant pathologies in the maxillofacial 
region, and the evaluation of susceptible metastatic lymph nodes present in the neck, are of great 
importance when choosing the best treatment for those patients; it is also critical to predict 
prognosis [5,6,7]. To date, the most accurate method for finding metastases in the neck is neck 
dissection with excision of the primary tumor [8].In cases of T2 lip cancer reported in the literature, occult metastases were present in 15–35% of 
cases. There is no safe prognosis for which to recommend elective neck dissection [9]. The presence
of lymph node metastases is the main prognostic factor. Most methods used to detect susceptible 
metastases in the neck in patients with malignant pathologies in the maxillofacial region are not 
completely accurate. CT, MRI and ultrasound can detect lymph nodes, but not metastases. Sentinel 
node biopsy (SNB) is most advantageous in detecting metastases in neck lymph nodes, and leads to 
an accurate diagnosis and prognosis, especially in patients with N0[9], and may help in the 
treatment of these patients[10].
Material and Methods
This prospective clinical study was undertaken in the Department of Maxillofacial Surgery and the 
Department of Radiology-Nuclear Medicine at the University Clinical Center of Kosova. Ethical 
approval was issued by the Ethics Committee of the Faculty of Medicine, University Of Prishtina 
(document Nr.1551, 30.03.2010).
Between April 2010 and January 2011, 31 patients with SCC of the lower lip were admitted to the 
Maxillofacial Surgery Clinic of the University Clinical Center of Kosova. This study enrolled 
patients aged 18 years and older, with SCC of the lower lip with TNM classification cT1, cT2 and 
cN0, with an indication for surgical intervention. Patients excluded from study included those 
treated with radiotherapy before surgery, with recurrent carcinoma, or with lower lip carcinoma T3 
and T4.
In all patients, clinically relevant data (including exposure to sun and tobacco use) were collected, 
and clinical examination (correct examination of oral cavity and oropharynx) was performed. In 
suspicious cases, an incision biopsy was done, along with additional examinations such as 
orthopantomography and dental status. To detect lymph nodes in the neck lymphoscintigraphy 
(LSG) of the neck was acquired. LSG was performed on the same day as surgery, after intradermal injection of 37Mbq Tc99m-Sn-colloid/ml at four peritumoral sites. In patients with positive 
Lymphoscyntigraphy  results, sentinel lymph nodes  were extracted surgically. The extracted nodes 
were sent to the Institute for Pathology, University Clinical Center of Kosova, for histopathological 
analysis.
Results 
Of the 31 patients enrolled in the study, three (9.7%) were female and 28 (90.3%) male. Results are 
statistically significant by gender (χ
2-test = 20.16; P<0.001).  More than half of the patients (61.3%)
were aged over 60 years. SCC of the lower lip most often occurred in the group of patients aged 
60–69 years (Table 1).
Table 1. Patient population by age group
Age
Gender
Fem
ale
Male
No No No %
30–
39
- 2 2 6.5
40–
49
- 5 5 16.1
50–
59
- 5 5 16.1
60–
69
1 8 9 29.0
70–
79
- 7 7 22.6
80–
89
2 1 3 9.7LSG was more often positive for detection of neck lymph nodes in patients with T2 carcinoma of
the lower lip compared with T1 (88.9% vs. 59.1%), although this was not statistically significant (P
= 0.205; Table 2).
Table 2. Results of LSG
LSG
T1 T2 Total
Number
of cases %
Number
of cases %
Number
of cases %
Positive 13 59.1 8 88.9 21 67.7
Negative 9 40.9 1 11.1 10 32.3
Sentinel Node Biopsy (SNB) was performed in all 21 patients with a positive LSG finding.
Metastases were confirmed in 10 patients (47.6%). 
Among these 21 patients, 14 (66.7%) had had the disease for more than 1 year, while in seven 
(33.3%), the disease was present for less than 1 year (P < 0.05; Table 3)
Table 3. Results of LSG by duration of pathology
Duration of
pathology 
LSG
Negative Positive
N % N % N %
>1
year 2 20.0 14 66.7 16 51.6
<1
year 8 80.0 7 33.3 15 48.4
P=0.023
SNB in patients with positive LSG was positive in 10 of the 21 patients (47.6%). Of 14 patients
who had the disease for more than 1 year, SNB was positive in nine (64.3%). SNB was more oftenpositive in cases with pathology present for more than 1 year (P < 0.05; Table 4).
Table 4. Results of SNB by duration of pathology
Sentinel node
biopsy
Duration of pathology
>1 
year < 1 year
N % N % N %
Nega
tive 5 35.7 6 85.7 11 52.4
Posit
ive 9 64.3 1 14.3 10 47.6
P<0.05
Among all 31 patients enrolled in this study, SNB was positive in 10 patients (32.3%). Occult 
metastases in this study were present in 32.3% of cases (Table 5).
Table 5. Positive lymph nodes by SNB in all patients 
SNB
Right site Left site Medial part
N % N % N % N %
Neg
ative 8 72.7 10 71.4 3 50.0 21 67.7
Posit
ive 3 27.3 4 28.6 3 50.0 10 32.3
Discussion 
In clinical practice, CT and MRI are commonly used to detect neck metastases. It is well known
that enlarged lymph nodes do not indicate metastasis, while non-enlarged lymph nodes do not
indicate that metastases are present. Therefore, the accuracy of CT, MRI or ultrasound is not
sufficiently high for detection of metastatic lymph nodes in the neck[8]. In the literature, FDG-PETshows a similar frequency of detection of primary tumors as CT and MRI, but is better for the
detection of lymph node metastases[11]. Intraoperative lymphatic mapping with different methods
such as LSG combined with SNB, however, is the most accurate method in patients with T1, T2 and
N0 SCC of the lower lip. LSG in patients with positive SNB can help to determine treatment in
patients with radical neck dissection, while those with negative SNB can avoid neck dissection and
opt to “wait and see”[12,13].
In patients with SCC in the oral cavity, LSG followed by radio-guided SNB is the best method to 
confirm the accuracy of SNB in predicting the presence of occult metastases. This method is 
designed to detect sentinel nodes that are almost always on the neck (levels I and II), thereby 
limiting the number of nodes examined and the extension of a surgical approach [14]. Dynamic or 
static LSG is especially beneficial in patients with T2, N0 disease, saving time and costs [15]. The 
recommended treatment protocol for T3 and T4 carcinoma of the lower lip is tumor excision with 
neck dissection.
A major problem in T1, T2 and N0 cases lies in the fact that the recommended protocol is to "wait
and see", despite the fact that occult metastasis in those cases occurs in 15–35% of patients [16].
Lower-lip SCC is not an aggressive tumor, which is why neck dissection in the early stages
generally underestimates the disease; however, the mortality of this pathology remains at 10–30%.
Recent  studies  appear  to show  that higher rates  of clinically  positive  neck were  initially
negative[1,17,18]. It should be noted that during this study we admitted  five patients (which were
not included in study) in our department who were operated before one or  half year before our
study and in that time they were T1-2,N0. Now, they came with palpable lymph nodes in submental
or submandibular region, with positive HP results for metastases.
Conclusion:
These results show that LSG combined with immediate SNB offers very good results for the
treatment of T1, T2 and N0 lower-lip carcinoma. Since occult metastasis occurred in 32,3 % of T1and T2 patients in this study, it would appear to be best to perform selective neck dissection in all
patients with lower-lip carcinoma.
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